NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call

    NEXT STORY
    Elixinol and KBMD Health Launch New Hemp CBD Extract
    PREV STORY
    Genmab Announces Data to be Presented at 2019 ASCO Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TLC Reports Second Quarter 2019 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News

    RadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumors

    Houston, TX (USA) and Courbevoie (France), Jan. 10, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. ...

    author_avatar
    NASDAQ Market News

    Loxo Oncology to Announce Second Quarter 2016 Financial Results

    STAMFORD, Conn., July 27, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News